Match Document Document Title
8173438 Microbiological assessment method and device utilizing oxygen gradient sensing  
There is disclosed a biological indicator (BI) test utilizing oxygen sensing within a microenvironment as a means for determining the presence of viable microorganisms capable of growth, a method...
8158107 Genes and proteins associated with angiogenesis and uses thereof  
Disclosed is a panel of biomarkers associated with angiogenesis, and the use of such biomarkers (genes, proteins, homologues and analogs thereof) to regulate angiogenesis. Methods for identifying...
8158379 Methods for determining microbial contamination of allograft products  
A method for determining microbial contamination of allograft products includes providing an extraction vessel having an outer container and a removable inner basket, placing the allograft product...
8143018 Method for preparing a measurement sample for detecting live cells of a microorganism in a test sample  
According to the following steps, live cells, injured cells, VNC cells and dead cells of a microorganism in a test sample are detected by flow cytometry: a) the step of treating the test sample...
8110375 High throughput assay for cancer cell growth inhibition  
A high-throughput, anchorage-independent assay is described, which screens compounds for inhibition of cancer cell growth. The assay utilizes a three-dimensional matrix or semi-solid media...
8106152 Antimicrobial composition  
The present invention relates to novel antimicrobial composition comprising a peptide which can be obtained from the milk protein casein or chemically synthesised or produced by recombinant DNA...
8097434 Methods for the detection of beta-lactamases  
Presented herein are methods and compositions for the detection of specific beta-lactamases, including class A serine carbapenemases, metallo-beta-lactamases. AmpC beta-lactamases, and...
8092810 Use of polypeptides having antimicrobial activity  
The present invention relates to the use of polypeptides related to a Bacillus licheniformis polypeptide (amino acids 1-85 of SEQ ID NO: 2) as antimicrobial agents, for example in pharmaceutical...
8080370 Screening method for prophylactic and/or therapeutic agent for disease accompanied by hepatitis C  
An easy and efficient screening method for an agent useful for prevention and/or treatment of hepatitis C virus-related disease, and a prophylactic and/or therapeutic agent for hepatitis C...
8058025 Methods for determining efficacy of chemotherapeutic agents  
An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested,...
8034580 Determining presence of antibiotic in a fluid  
The pressure of an antibiotic in a fluid is determined by contacting a sample of the fluid suspected of containing an antibiotic with a test medium containing a microorganism, a substance that...
8026079 Method for detection of microorganism and kit for detection of microorganism  
According to the following steps, live cells, injured cells, VNC cells and dead cells of a microorganism in a test sample are detected by flow cytometry: a) the step of treating the test sample...
8012711 Methods of screening for compounds that reduce microbial resistance to fluoroquinolones  
The instant methods and compositions represent an advance in controlling drug resistance in microbes. AcrAB-like efflux pumps have been found to control resistance to drugs, even in highly...
8012492 In vitro model of latent mycobacterial infection  
A method of inducing latency in Mycobacterium permits preparation of an in vitro model system of latent mycobacterial infection. Latency is induced in a pure culture of Mycobacterium by exposing it...
8012758 Method of monitoring microbiological activity in process streams  
An apparatus and method for monitoring microbiological activity in a process stream by measuring dissolved oxygen is disclosed. Bulk microbiological activity and surface associated biological...
7977092 Methods for identifying candidate anti-tumorigenic agents  
Methods for identifying stem cells and other cells specific to embryogenesis and carcinogenesis, classifying tissue samples, diagnosing precancerous and cancerous or atherosclerotic lesions,...
7960136 Direct antimicrobial susceptibility assay  
An antimicrobial susceptibility assay, including the steps of: providing an assay dish; providing a growth medium in said dish; providing an antimicrobial agent sample; providing an interpretive...
7955817 Vaccine protection assay  
The present invention relates to the field of Serum Bactericidal Activity (SBA) assays for Gram negative bacteria, in particular N. meningitidis. The SBA assay is the most important method for...
7947435 Neuronal regeneration material screening method by ex vivo model  
The present invention relates to a neuronal regeneration material screening method using ex vivo models, more precisely a neuronal regeneration material screening method using an organotypic spinal...
7939314 Methods and compositions for rapidly detecting and quantifying viable Legionella  
Methods and compositions detect and quantify viable Legionella. Dip-slides that include an absorbent medium, growth promoting, and growth selective substances are useful in rapid detection and...
7935521 Methods and compositions for rapidly detecting and quantifying viable Legionella  
Methods and compositions detect and quantify viable Legionella. Dip-slides that include an absorbent medium, growth promoting, and growth selective substances are useful in rapid detection and...
7932051 Blood and urine test  
The present invention provides a test medium comprising a test microorganism, an indicator and a metal in ionized form, wherein the valence of said metal is at least 2 and the concentration of said...
7928215 Methods of screening for compounds that inhibit the biosynthesis of GPI in malaria parasites  
The present inventors succeeded in isolating GWT1 (PfGWT1), which is one of the enzymes involved in GPI biosynthesis in the malaria parasite P. falciparum. In addition, the inventors revealed that...
7923204 Forward mutation assay based on 5-fluorouracil resistance  
Disclosed herein is a novel forward mutation assay based on 5-fluorouracil (5-FU) resistance which utilizes a strain of Salmonella typhimurium derived from the Ames strain TA100. More specifically,...
7901932 Methods and compositions for rapidly detecting and quantifying viable Legionella  
Methods and compositions detect and quantify viable Legionella and other heterotrophic aerobic bacteria. Dip-slides that include an absorbent medium, growth promoting, and growth selective...
7901903 ***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Determining presence of antibiotic in a fluid
 
The pressure of an antibiotic in a fluid is determined by contacting a sample of the fluid suspected of containing an antibiotic with a test medium containing a microorganism, a substance that...
7897365 Method for adjusting antibiotic sensitivity of a test culture  
The present invention relates to a method for adjusting the sensitivity of a microbial culture to an antibiotic. The method employs a substance derived from a bacterial species with sensitivity to...
7892782 Screening process for antibacterial agents  
The present invention relates to a method of preparing a phenotypically antibiotic-resistant subpopulation of stationary phase bacteria by treating stationary phase bacteria with high doses of...
7888005 Inhibitors of macromolecular activity  
The present invention relates generally to methods, kits, compositions, and combinations to identify anti-infective or anti-pathogenic agents. The present invention also relates to methods, kits,...
7883711 Use of polypeptides having antimicrobial activity  
The present invention relates to the use of polypeptides related to a Bacillus licheniformis polypeptide (amino acids 1-85 of SEQ ID NO: 2) as antimicrobial agents, for example in pharmaceutical...
7879576 Marine actinomycete taxon for drug and fermentation product discovery  
The invention is the discovery of an actinomycete genus, given the name Salinospora gen. nov., that displays an obligate requirement of seawater (Na+) for growth and unique 16S rRNA signature...
7871790 Anthrax bioassays and methods of treating and diagnosing anthrax infection  
Based on the observation that exposure of cells or animals to anthrax lethal toxin results in activation of the intracellular enzyme caspase-1/IL-1 converting enzyme (ICE), which, in turn, leads to...
7867758 Bioluminogenic assay system for measuring beta-lactamase activity  
A bioluminogenic assay system including: providing a bioluminogenic substrate incorporating a beta-lactam antibiotic, a bioluminescence initiating compound, and a chemical linkage joining the...
7837947 Sample mixing on a microfluidic device  
Mixing structures for use on sample processing devices are disclosed. The mixing structures include one or more mixing chambers in fluid communication with a process chamber, such that changing the...
7829305 Method for monitoring the presence of biofilmforming microorganisms in paper industry  
The invention is directed to a method for detecting the presence of biofilm-forming microorganisms in a paper or board making process for determining the need of an anti-biofilm agent in the...
7824882 Oligosaccharides in a test system for the determination of the presence of an antibiotic in a fluid  
Provided is a test system, a test method and a test kit for the determination of the presence of an antibiotic in a fluid based on a test medium comprising a test organism, at least one substance...
7807403 Device and direct method for detection of antibiotic-inactivating enzymes  
A method for determining whether a microorganism produces an AmpC β-lactamase is disclosed in which a culture of a microorganism suspected of producing a β-lactamase that inactivates a β...
7794967 Method and kit for detection of novel pathogen inhibitors  
The present invention relates to a method for detection of novel pathogen inhibitors using models of pathogen specific, and metal binding structures/domains representing essential cellular...
7781186 Screening methods using normal human liver cell line  
In this application is described the establishment and maintenance of a normal human hepatocyte cell line able to support complete development of malaria parasite development in vitro. The cell...
7776527 Methods and compositions for reducing microbial induced apoptosis  
The present invention relates to microbial infection, and in particular, the reduction of apoptosis associated with microbial infection, the screening of agents that reduce apoptosis, and the...
7771963 Methods for determining efficacy of chemotherapeutic agents  
An improved system for screening a multiple of candidate therapeutic or chemotherapeutic agents for efficacy as to a specific patient, in which a tissue sample from the patient is harvested,...
7736588 Apparatus and method for detecting undesired residues in a sample  
Detection arrangement and method for detecting presence of a residue in a sample include determining color values of the sample, associated with the L*a*b color model. A value of a composite...
7727731 Potent, selective and non toxic c-kit inhibitors  
The present invention relates to a screening method allowing the identification and selection of compounds targeting the transphosphorylase (also called phosphotransferase) domain of c-kit, more...
7718392 Device and direct method for detecting antibiotic-inactivating factors  
The present invention provides a method of determining the antibiotic susceptibility of a microorganism comprising the following steps. First, a culture of the microorganism whose susceptibility is...
7709246 Device and method for detecting bioelectric signals from electrophysiologically active regions in spheroids  
Disclosed is a device for detecting bioelectric signals from spheroids comprising a measuring chamber having a measuring chamber wall which encloses a volume, which is open at least at one side, is...
7670797 Method of determining toxicity with three dimensional structures  
A method of determining toxicity of a test agent in a tissue including A) incubating a test agent within a three-dimensional tissue engineered structure comprising a first mold or polymer scaffold,...
7648830 Method for determining the presence of bacteria resistant to cell lysing antibiotics  
A method is provided for determining the presence of a target bacteria based on its resistance to a cell lysing antibiotic. Said antibiotic is used to lyse cells of non-target bacteria in a sample...
7642068 Multiple-valent opsonophagocytic assay selection panel arrays and uses therefor  
This application discloses a multivalent opsonophagocytosis assay that does not rely on counting of bacterial colonies to determine bacteria viability following opsonophagocytosis. Instead, the...
7632657 Method of detecting meticillin-resistant microorganisms  
The invention relates to a novel solid medium for detecting meticillin-resistant micro-organisms, containing an antibiotic selected from the cephalosporin group, particularly second and third...
7629141 Essential and important genes of Pseudomonas aeruginosa and the use thereof to design or identify antibacterial agents  
The invention includes a database of candidate essential genes in Pseudomonas aeruginosa, as well as other important genes that, when mutated, lead to a growth attenuated phenotype. Such genes and...